What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1
use it alongside your prescribers guidance
*In a study of 3,250 WW Clinic patients, patients that were prescribed a GLP-1 lost on average 21% of their body weight at 12 months
Obes Sci Amp Pract (2019) 5:36675
However, unlike the combination of exercise and liraglutide, liraglutide alone resulted in a decrease in hip and lumbar spine BMD compared to placebo
Common incretin-related effects discussed in the broader GLP-1 and metabolic drug class may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but trial observations do not establish safe personal use of a research peptide